SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001157523-13-002606
Filing Date
2013-05-10
Accepted
2013-05-10 16:54:16
Documents
11
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 AKORN, INC. 10-Q a50628988.htm 10-Q 963507
2 EXHIBIT 31.1 a50628988ex31_1.htm EX-31.1 11745
3 EXHIBIT 31.2 a50628988ex31_2.htm EX-31.2 12007
4 EXHIBIT 32.1 a50628988ex32_1.htm EX-32.1 6449
5 EXHIBIT 32.2 a50628988ex32_2.htm EX-32.2 6191
  Complete submission text file 0001157523-13-002606.txt   7368916

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT akrx-20130331.xml EX-101.INS 1091346
7 XBRL TAXONOMY EXTENSION SCHEMA akrx-20130331.xsd EX-101.SCH 46114
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE akrx-20130331_cal.xml EX-101.CAL 70052
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE akrx-20130331_def.xml EX-101.DEF 213217
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE akrx-20130331_lab.xml EX-101.LAB 720134
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE akrx-20130331_pre.xml EX-101.PRE 393835
Mailing Address 1925 W. FIELD COURT, SUITE 300 LAKE FOREST IL 60045
Business Address 1925 W. FIELD COURT, SUITE 300 LAKE FOREST IL 60045 847-279-6100
AKORN INC (Filer) CIK: 0000003116 (see all company filings)

IRS No.: 720717400 | State of Incorp.: LA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32360 | Film No.: 13834242
SIC: 2834 Pharmaceutical Preparations